These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1835517)

  • 21. [Persistence of anti-HB antibodies after vaccination against hepatitis B in medical staff of the Memorial Child Health Institute in 1994-1998].
    Migdał A; Nowak-Parzygnat B; Madaliński K
    Med Pr; 2003; 54(5):445-52. PubMed ID: 14978893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatitis B vaccination in nursing personnel. Experiences in an institute for mentally handicapped].
    Illichmann HR; Schmidt W; Plassmann E
    Fortschr Med; 1990 Jul; 108(22):425-8. PubMed ID: 2143992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The comparison of dynamics in humoral responses in health personnel after vaccination against hepatitis B using Engerix B and Gen-H-B-vax].
    Rokossowski H; Juszczyk J
    Przegl Epidemiol; 1992; 46(4):263-9. PubMed ID: 1305774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for hepatitis B at a residential institution for intellectually handicapped persons.
    Stehr-Green P; Wilson N; Miller J; Lawther A
    N Z Med J; 1991 Dec; 104(925):514-6. PubMed ID: 1836843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The level of anti-HBs in blood serum of persons selected from a group of Krakow inhabitants].
    Lutyński R; Juszczyk R
    Folia Med Cracov; 1997; 38(3-4):63-8. PubMed ID: 10481383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of hepatitis B vaccine immunity in hemodialysis patients.
    Ramezani A; Velayati AA; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
    Ther Apher Dial; 2008 Apr; 12(2):143-6. PubMed ID: 18387163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients].
    Urbanowicz W
    Przegl Epidemiol; 2000; 54(3-4):343-50. PubMed ID: 11349597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of neonatal vaccination against hepatitis B in Frosinone].
    Gallo IA; Petrosillo N; Celletti S; Tersigni I; Corbo A; Antonelli L; Maddaluno R; Mancini E; Ceccarelli A; Cestra S
    Ann Ig; 1989; 1(3-4):709-15. PubMed ID: 2483642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is it necessary to revaccinate against hepatitis B virus when the titer of anti-HBs drops below 10 IU/L?].
    Polák P; Husa P; Smejkal P; Kamelander J; Chlupová G; Penka M
    Klin Mikrobiol Infekc Lek; 2016 Sep; 22(3):125-130. PubMed ID: 27907975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survey of the level of anti-HBs antibody titer in vaccinated Iranian general dentists.
    Alavian SM; Izadi M; Zare AA; Lankarani MM; Assari S; Vardi MM
    Spec Care Dentist; 2008; 28(6):265-70. PubMed ID: 19068068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Massé R; Duval B
    Vaccine; 2009 Oct; 27(43):6048-53. PubMed ID: 19683086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous vaccination against hepatitis A and B: results of an open, randomized study from the occupational health point of view.
    Rieger MA; Hofmann F; Michaelis M
    Int J Occup Med Environ Health; 2004; 17(3):379-91. PubMed ID: 15683159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of hepatitis B preventive vaccination].
    Hofmann F; Kralj N; Hasselhorn HM; Nübling M; Michaelis M; Berthold H
    Gesundheitswesen; 1997; 59(8-9):527-34. PubMed ID: 9440917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
    Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
    Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suboptimal response to hepatitis B vaccine in drug users.
    Rumi M; Colombo M; Romeo R; Boschini A; Zanetti A; Gringeri A; Mannucci PM
    Arch Intern Med; 1991 Mar; 151(3):574-8. PubMed ID: 1848057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W; Muszyńska M; Pawłowska M
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of vaccine potency against viral hepatitis B performed with HB-vax II vaccine in a group with an increased risk for hepatitis B].
    Leśnik J; Cieślak A; Krychniak E; Sitkiewicz D
    Pol Merkur Lekarski; 1996 Oct; 1(4):249-51. PubMed ID: 9156936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.